(redirected from Bloxiverz)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Bloxiverz: neostigmine, neostigmine methylsulfate


 (nē′ō-stĭg′mēn, -mĭn)
A cholinesterase inhibitor that is given in the form of a bromide salt, C12H19BrN2O2, or a methyl sulfate, C13H22N2O6S, used to treat myasthenia gravis and muscle atony and to reverse the effects of muscle relaxants after surgery.


(Pharmacology) pharmacol a cholinergic drug which acts as a muscle stimulant and is used primarily to treat myasthenia gravis


(ˌni oʊˈstɪg min, -mɪn)

a synthetic anticholinesterase, C12H19N2O2, used in the treatment of myasthenia gravis, glaucoma, and postoperative urinary bladder distention.
[1940–45; neo- + (physo)stigmine]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neostigmine - a cholinergic drug (trade name Prostigmin) used to treat some ophthalmic conditions and to treat myasthenia gravis
anticholinesterase - a medicine that inhibits cholinesterase by combining with it and so has a cholinergic effect


n neostigmina
References in periodicals archive ?
Additional drugs from that portfolio comprise Bloxiverz and Vaculep, which Flamel officials stated have led to significant cash flow.
Flamel currently has approvals for and markets two previously Unapproved Marketed Drugs in the USA, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection).
The company said the Q2 2015 total revenues comprised of net sales of Bloxiverz of USD45.